Cargando…

Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis

INTRODUCTION: Antibiotics are routinely given to people with chronic obstructive pulmonary disease (COPD) presenting with lower respiratory tract infection (LRTI) symptoms in primary care. Population prescribing habits and their consequences have not been well-described. METHODS: We conducted a retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolbrink, Marie, Bonnett, Laura J, Blakey, John D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797433/
https://www.ncbi.nlm.nih.gov/pubmed/31681477
http://dx.doi.org/10.1136/bmjresp-2019-000458
_version_ 1783459826856099840
author Stolbrink, Marie
Bonnett, Laura J
Blakey, John D
author_facet Stolbrink, Marie
Bonnett, Laura J
Blakey, John D
author_sort Stolbrink, Marie
collection PubMed
description INTRODUCTION: Antibiotics are routinely given to people with chronic obstructive pulmonary disease (COPD) presenting with lower respiratory tract infection (LRTI) symptoms in primary care. Population prescribing habits and their consequences have not been well-described. METHODS: We conducted a retrospective analysis of antibiotic prescriptions for non-pneumonic exacerbations of COPD from 2010 to 2015 using the UK primary care Optimum Patient Care Research Database. As a proxy of initial treatment failure, second antibiotic prescriptions for LRTI or all indications within 14 days were the primary and secondary outcomes, respectively. We derived a model for repeat courses using univariable and multivariable logistic regression analysis. RESULTS: A total of 8.4% of the 9042 incident events received further antibiotics for LRTI, 15.5% further courses for any indication. Amoxicillin and doxycycline were the most common index and second-line drugs, respectively (58.7% and 28.7%), mostly given for 7 days. Index drugs other than amoxicillin, cardiovascular disease, pneumococcal vaccination and more primary care consultations were statistically significantly associated with repeat prescriptions for LRTI (p<0.05). The ORs and 95% CIs were: OR 1.28, 95% CI 1.10 to 1.49; OR 1.37, 95% CI 1.13 to 1.66; OR 1.33, 95% CI 1.14 to 1.55 and OR 1.05, 95% CI 1.02 to 1.07, respectively. Index duration, inhaled steroid use and exacerbation frequency were not statistically significant. The derived model had an area under the curve of 0.61, 95% CI 0.59 to 0.63. DISCUSSION: The prescription of multiple antibiotic courses for COPD exacerbations was relatively common—one in twelve patients receiving antibiotics for LRTI had a further course within 2 weeks. The findings support the current preference for amoxicillin as index drug within the limitations of this observational study. Further clinical trials to determine best practice in this common clinical situation appear required.
format Online
Article
Text
id pubmed-6797433
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67974332019-11-01 Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis Stolbrink, Marie Bonnett, Laura J Blakey, John D BMJ Open Respir Res Chronic Obstructive Pulmonary Disease INTRODUCTION: Antibiotics are routinely given to people with chronic obstructive pulmonary disease (COPD) presenting with lower respiratory tract infection (LRTI) symptoms in primary care. Population prescribing habits and their consequences have not been well-described. METHODS: We conducted a retrospective analysis of antibiotic prescriptions for non-pneumonic exacerbations of COPD from 2010 to 2015 using the UK primary care Optimum Patient Care Research Database. As a proxy of initial treatment failure, second antibiotic prescriptions for LRTI or all indications within 14 days were the primary and secondary outcomes, respectively. We derived a model for repeat courses using univariable and multivariable logistic regression analysis. RESULTS: A total of 8.4% of the 9042 incident events received further antibiotics for LRTI, 15.5% further courses for any indication. Amoxicillin and doxycycline were the most common index and second-line drugs, respectively (58.7% and 28.7%), mostly given for 7 days. Index drugs other than amoxicillin, cardiovascular disease, pneumococcal vaccination and more primary care consultations were statistically significantly associated with repeat prescriptions for LRTI (p<0.05). The ORs and 95% CIs were: OR 1.28, 95% CI 1.10 to 1.49; OR 1.37, 95% CI 1.13 to 1.66; OR 1.33, 95% CI 1.14 to 1.55 and OR 1.05, 95% CI 1.02 to 1.07, respectively. Index duration, inhaled steroid use and exacerbation frequency were not statistically significant. The derived model had an area under the curve of 0.61, 95% CI 0.59 to 0.63. DISCUSSION: The prescription of multiple antibiotic courses for COPD exacerbations was relatively common—one in twelve patients receiving antibiotics for LRTI had a further course within 2 weeks. The findings support the current preference for amoxicillin as index drug within the limitations of this observational study. Further clinical trials to determine best practice in this common clinical situation appear required. BMJ Publishing Group 2019-09-17 /pmc/articles/PMC6797433/ /pubmed/31681477 http://dx.doi.org/10.1136/bmjresp-2019-000458 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Chronic Obstructive Pulmonary Disease
Stolbrink, Marie
Bonnett, Laura J
Blakey, John D
Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
title Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
title_full Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
title_fullStr Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
title_full_unstemmed Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
title_short Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
title_sort antibiotics for copd exacerbations: does drug or duration matter? a primary care database analysis
topic Chronic Obstructive Pulmonary Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797433/
https://www.ncbi.nlm.nih.gov/pubmed/31681477
http://dx.doi.org/10.1136/bmjresp-2019-000458
work_keys_str_mv AT stolbrinkmarie antibioticsforcopdexacerbationsdoesdrugordurationmatteraprimarycaredatabaseanalysis
AT bonnettlauraj antibioticsforcopdexacerbationsdoesdrugordurationmatteraprimarycaredatabaseanalysis
AT blakeyjohnd antibioticsforcopdexacerbationsdoesdrugordurationmatteraprimarycaredatabaseanalysis